Immunomodulation with intrathymic injection of donor splenocytes followed by CTLA4Ig therapy prolongs small intestinal allograft survival.
Greenstein
S M
SM
Department of Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York 10467, USA.
Sun
S
S
Schechner
R S
RS
Tellis
V A
VA
D000069594:Abatacept; D000818:Animals; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D060908:CTLA-4 Antigen; D006085:Graft Survival; D006086:Graft vs Host Disease / Q000517:prevention & control; D018796:Immunoconjugates; D007165:Immunosuppression Therapy / Q000379:methods*; D007421:Intestine, Small / Q000637:transplantation*; D017710:Lymphocyte Transfusion; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D013154:Spleen; D013601:T-Lymphocytes / Q000276:immunology*; D014184:Transplantation, Homologous / Q000276:immunology*
D015703:Antigens, CD; D000943:Antigens, Differentiation; D000961:Antilymphocyte Serum; D060908:CTLA-4 Antigen; D018796:Immunoconjugates; D000069594:Abatacept